Epigral Ltd

BSE :543332 NSE :EPIGRAL Sector : Chemica..
1,774.80
Change: 71.45(4.19%)
52 week Low
950.25
52 week High
2,406.75
Day low
1,677.80
Day high
1,788
Prev Close
1,703.35
Open
1,677.80
6M return
-5.76%
1Y return
63.71%
MCap(Rs. in Cr.)
7,348.48
Total Volume
39,796
Face Value : 10
Listed Since
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
0
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
0
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
0
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)
0

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales


Sales Industry Avg


PAT


PAT Industry Avg


No data available
No data available


Relative to Sensex rtn in 3 year


Relative to Nifty rtn in 3 year


Relative to top 3 MF rtn in 3 year


2016 2014 2014
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Epigral
1,774.80
Change: 71.45 (4.19%)
1 Year return
63.71%
Risk (Std Dev)
0.13%
PE Ratio
21.05293
MCap( in Cr.)
7,348.48
Pidilite Inds.
2,757.75
Change: -8.80 (-0.32%)
1 Year return
1.72%
Risk (Std Dev)
0.05%
PE Ratio
70.18269
MCap( in Cr.)
1,40,719.89
SRF
2,732.70
Change: -8.40 (-0.31%)
1 Year return
16.43%
Risk (Std Dev)
0.10%
PE Ratio
70.85552
MCap( in Cr.)
81,253.01
Linde India
5,802.85
Change: 259.70 (4.69%)
1 Year return
0.41%
Risk (Std Dev)
0.14%
PE Ratio
107.15499
MCap( in Cr.)
47,271.98
Gujarat Fluoroch
3,640.10
Change: -28.40 (-0.77%)
1 Year return
4.46%
Risk (Std Dev)
0.15%
PE Ratio
88.13659
MCap( in Cr.)
40,298.47
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth 0 with a of 0%

News

Stay tuned to the latest developments and happenings in the company.

Epigral consolidated net profit rises 111.15% in the December 2024 quarter

Net profit of Epigral rose 111.15% to Rs 103.63 crore in the quarter ended December 2024 as against Rs 49.08 crore during the previous quarter ended D....

27 Jan 2025 16:58

Board of Epigral recommends Interim Dividend

Epigral announced that the Board of Directors of the Company at its meeting held on 27 January 2024, has recommended a Interim dividend of Rs.2.5 per ....

27 Jan 2025 14:29

Epigral declare Quarterly Result

Epigral will hold a meeting of the Board of Directors of the Company on 27 January 2025.Powered by Capital Market - Live News

20 Jan 2025 13:44

Epigral consolidated net profit rises 114.00% in the September 2024 quarter

Net profit of Epigral rose 114.00% to Rs 81.30 crore in the quarter ended September 2024 as against Rs 37.99 crore during the previous quarter ended S....

09 Nov 2024 14:27

Board of Epigral approves doubling of capacity at Dahej

The Board of Epigral at its meeting held on 09 November 2024 has approved the expansion of production capacity of Chlorinated Polyvinyl Chloride Resin....

09 Nov 2024 13:31

Epigral consolidated net profit rises 172.52% in the June 2024 quarter

Net profit of Epigral rose 172.52% to Rs 85.87 crore in the quarter ended June 2024 as against Rs 31.51 crore during the previous quarter ended June 2....

24 Jul 2024 14:12

View More
Subscribe for our
newsletter
Open Account Now